Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma
暂无分享,去创建一个
P. Laurent-Puig | P. Dessen | M. Riquet | C. Houdayer | H. Blons | D. Le Corre | C. Danel | E. Fabre-Guillevin | K. Pallier | M. Tremblay-Gravel
[1] Derek Y. Chiang,et al. Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.
[2] S. Hirohashi,et al. Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma , 2007, Cancer science.
[3] P. Hainaut,et al. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history. , 2007, Cancer research.
[4] L. Holmberg,et al. Lung cancer incidence in never smokers. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Rameen Beroukhim,et al. Single nucleotide polymorphism array analysis of cancer , 2007, Current opinion in oncology.
[6] P. Laurent-Puig,et al. Epidermal Growth Factor Receptor Mutation in Lung Cancer are Linked to Bronchioloalveolar Differentiation , 2006, The American journal of surgical pathology.
[7] J. Minna,et al. Exclusive mutation in epidermal growth factor receptor gene, HER‐2, and KRAS, and synchronous methylation of nonsmall cell lung cancer , 2006, Cancer.
[8] M. Morita,et al. The methylation status and protein expression of CDH1, p16INK4A, and fragile histidine triad in nonsmall cell lung carcinoma , 2006 .
[9] Wing Hung Wong,et al. Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays , 2006, PLoS Comput. Biol..
[10] K. Kelsey,et al. Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer , 2006, International journal of cancer.
[11] S. Toyooka,et al. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. , 2006, Cancer research.
[12] Cheng Li,et al. Allele-Specific Amplification in Cancer Revealed by SNP Array Analysis , 2005, PLoS Comput. Biol..
[13] S. Hirohashi,et al. Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features , 2005, Clinical Cancer Research.
[14] Shigeru Chiba,et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.
[15] M. Meyerson,et al. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. , 2005, Cancer research.
[16] J. Nesland,et al. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome , 2005, Journal of Clinical Pathology.
[17] A. Marchetti,et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Joachim Herz,et al. Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers? , 2004, Trends in molecular medicine.
[19] H. Michel,et al. The MAM (Meprin/A5-protein/PTPmu) Domain Is a Homophilic Binding Site Promoting the Lateral Dimerization of Receptor-like Protein-tyrosine Phosphatase μ* , 2004, Journal of Biological Chemistry.
[20] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[21] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[22] David C Christiani,et al. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines , 2004, Oncogene.
[23] M. Shapero,et al. High-resolution analysis of DNA copy number using oligonucleotide microarrays. , 2004, Genome research.
[24] Avrum Spira,et al. Gene expression in lung adenocarcinomas of smokers and nonsmokers. , 2003, American journal of respiratory cell and molecular biology.
[25] D. Sidransky,et al. Cigarette smoking is strongly associated with mutation of the K‐ras gene in patients with primary adenocarcinoma of the lung , 2001, Cancer.
[26] J. Minna,et al. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. , 2000, Cancer research.
[27] H. Dosaka-akita,et al. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome , 1999, British Journal of Cancer.
[28] J. Luketich,et al. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[29] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[30] 仲田 庄志. The methylation status and protein expression of CDH1, p16[INK4A], and fragile histidine triad in nonsmall cell lung carcinoma : epigenetic silencing, clinical features, and prognostic significance , 2006 .
[31] M. Morita,et al. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. , 2006, Cancer.
[32] A. Borczuk,et al. Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers. , 2003, Lung cancer.
[33] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] Pre-publication history , 2001 .
[35] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.